31. K. Chen, P.S. Conti, Target-specific delivery of peptide-based probes for PET imaging. Adv.
Drug Deliv. Rev. 62(11), 1005–1022 (2010)
32. H. Xie, P. Diagaradjane, A.A. Deorukhkar, B. Goins, A. Bao, W.T. Phillips et al., Integrin
alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and
therapy. Int. J. Nanomed. 6, 259–269 (2011)
33. C. Glaus, R. Rossin, M.J. Welch, G. Bao, In vivo evaluation of
64 Cu-labeled magnetic
nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug. Chem. 21(4), 715–722
(2010)
34. B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of
64
Cu-labeled magnetic
nanoparticles for multimodal imaging. Bioconjug. Chem. 19(7), 1496–1504 (2008)
35. H.Y. Lee, Z. Li, K. Chen, A.R. Hsu, C. Xu, J. Xie et al., PET/MRI dual-modality tumor
imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 49(8), 1371–1379 (2008)
36. Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun et al., In vivo biodistribution and
highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2(1), 47–52
(2007)
37. A.L. Petersen, T. Binderup, P. Rasmussen, J.R. Henriksen, D.R. Elema, A. Kjaer et al.,
64
Cu
loaded liposomes as positron emission tomography imaging agents. Biomaterials 32(9),
2334–2341 (2011)
38. J. Guo, X. Zhang, Q. Li, W. Li, Biodistribution of functionalized multiwall carbon nanotubes
in mice. Nucl. Med. Biol. 34(5), 579–583 (2007)
39. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato et al., Tissue
biodistribution and blood clearance rates of intravenously administered carbon nanotube
radiotracers. Proc. Natl. Acad. Sci. U S A 103(9), 3357–3362 (2006)
40. M.R. McDevitt, D. Chattopadhyay, B.J. Kappel, J.S. Jaggi, S.R. Schiffman, C. Antczak
et al., Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl.
Med. 48(7), 1180–1189 (2007)
41. R. Zhang, W. Lu, X. Wen, M. Huang, M. Zhou, D. Liang et al., Annexin A5-conjugated
polymeric micelles for dual SPECT and optical detection of apoptosis. J. Nucl. Med. 52(6),
958–964 (2011)
42. J.C. Park, M.K. Yu, G.I. An, S.I. Park, J. Oh, H.J. Kim et al., Facile preparation of a hybrid
nanoprobe for triple-modality optical/PET/MR imaging. Small 6(24), 2863–2868 (2010)
43. J. Lee, T.S. Lee, J. Ryu, S. Hong, M. Kang, K. Im et al., RGD peptide-conjugated
multimodal NaGdF 4 :Yb
3+ /Er
3+ nanophosphors for upconversion luminescence, MR, and
PET imaging of tumor angiogenesis. J. Nucl. Med. 54(1), 96–103 (2013)
44. J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of
surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Magn. Mater. 277(1–2), 165–174 (2004)
45. S. Liang, Y. Wang, J. Yu, C. Zhang, J. Xia, D. Yin, Surface modified superparamagnetic
iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J. Mater.
Sci. Mater. Med. 18(12), 2297–2302 (2007)
46. Y.J. Chang, C.H. Chang, T.J. Chang, C.Y. Yu, L.C. Chen, M.L. Jan et al., Biodistribution,
pharmacokinetics and microSPECT/CT imaging of
188
Re-bMEDA-liposome in a C26
murine colon carcinoma solid tumor animal model. Anticancer Res. 27(4B), 2217–2225
(2007)
47. M. Luna-Gutiérrez, G. Ferro-Flores, B.E. Ocampo-García, C.L. Santos-Cuevas, N.
Jiménez-Mancilla, L.M. De León-Rodríguez et al., A therapeutic system of
177
Lu-labeled
gold nanoparticles-RGD internalized in breast cancer cells. J. Mex. Chem. Soc. 57, 212–219
(2013)
48. Y.K. Lee, J.M. Jeong, L. Hoigebazar, B.Y. Yang, Y.-S. Lee, B.C. Lee et al., Nanoparticles
modified by encapsulation of ligands with a long alkyl chain to affect multispecific and
multimodal imaging. J. Nucl. Med. 53(9), 1462–1470 (2012)
224
D. S. Lee et al.
Drug Deliv. Rev. 62(11), 1005–1022 (2010)
32. H. Xie, P. Diagaradjane, A.A. Deorukhkar, B. Goins, A. Bao, W.T. Phillips et al., Integrin
alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and
therapy. Int. J. Nanomed. 6, 259–269 (2011)
33. C. Glaus, R. Rossin, M.J. Welch, G. Bao, In vivo evaluation of
64 Cu-labeled magnetic
nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug. Chem. 21(4), 715–722
(2010)
34. B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of
64
Cu-labeled magnetic
nanoparticles for multimodal imaging. Bioconjug. Chem. 19(7), 1496–1504 (2008)
35. H.Y. Lee, Z. Li, K. Chen, A.R. Hsu, C. Xu, J. Xie et al., PET/MRI dual-modality tumor
imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 49(8), 1371–1379 (2008)
36. Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun et al., In vivo biodistribution and
highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2(1), 47–52
(2007)
37. A.L. Petersen, T. Binderup, P. Rasmussen, J.R. Henriksen, D.R. Elema, A. Kjaer et al.,
64
Cu
loaded liposomes as positron emission tomography imaging agents. Biomaterials 32(9),
2334–2341 (2011)
38. J. Guo, X. Zhang, Q. Li, W. Li, Biodistribution of functionalized multiwall carbon nanotubes
in mice. Nucl. Med. Biol. 34(5), 579–583 (2007)
39. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato et al., Tissue
biodistribution and blood clearance rates of intravenously administered carbon nanotube
radiotracers. Proc. Natl. Acad. Sci. U S A 103(9), 3357–3362 (2006)
40. M.R. McDevitt, D. Chattopadhyay, B.J. Kappel, J.S. Jaggi, S.R. Schiffman, C. Antczak
et al., Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl.
Med. 48(7), 1180–1189 (2007)
41. R. Zhang, W. Lu, X. Wen, M. Huang, M. Zhou, D. Liang et al., Annexin A5-conjugated
polymeric micelles for dual SPECT and optical detection of apoptosis. J. Nucl. Med. 52(6),
958–964 (2011)
42. J.C. Park, M.K. Yu, G.I. An, S.I. Park, J. Oh, H.J. Kim et al., Facile preparation of a hybrid
nanoprobe for triple-modality optical/PET/MR imaging. Small 6(24), 2863–2868 (2010)
43. J. Lee, T.S. Lee, J. Ryu, S. Hong, M. Kang, K. Im et al., RGD peptide-conjugated
multimodal NaGdF 4 :Yb
3+ /Er
3+ nanophosphors for upconversion luminescence, MR, and
PET imaging of tumor angiogenesis. J. Nucl. Med. 54(1), 96–103 (2013)
44. J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of
surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Magn. Mater. 277(1–2), 165–174 (2004)
45. S. Liang, Y. Wang, J. Yu, C. Zhang, J. Xia, D. Yin, Surface modified superparamagnetic
iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J. Mater.
Sci. Mater. Med. 18(12), 2297–2302 (2007)
46. Y.J. Chang, C.H. Chang, T.J. Chang, C.Y. Yu, L.C. Chen, M.L. Jan et al., Biodistribution,
pharmacokinetics and microSPECT/CT imaging of
188
Re-bMEDA-liposome in a C26
murine colon carcinoma solid tumor animal model. Anticancer Res. 27(4B), 2217–2225
(2007)
47. M. Luna-Gutiérrez, G. Ferro-Flores, B.E. Ocampo-García, C.L. Santos-Cuevas, N.
Jiménez-Mancilla, L.M. De León-Rodríguez et al., A therapeutic system of
177
Lu-labeled
gold nanoparticles-RGD internalized in breast cancer cells. J. Mex. Chem. Soc. 57, 212–219
(2013)
48. Y.K. Lee, J.M. Jeong, L. Hoigebazar, B.Y. Yang, Y.-S. Lee, B.C. Lee et al., Nanoparticles
modified by encapsulation of ligands with a long alkyl chain to affect multispecific and
multimodal imaging. J. Nucl. Med. 53(9), 1462–1470 (2012)
224
D. S. Lee et al.